Birmingham Clinical Research — Birmingham, Alabama

Birmingham Clinical Research is a clinical research site located in Birmingham, Alabama, United States 35209.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Birmingham Clinical Research has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Cardiovascular Disease.

Sponsors: Eli Lilly and Company, Amgen.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Birmingham Clinical Research?

Birmingham Clinical Research has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Birmingham Clinical Research conducted?

Birmingham Clinical Research has 4 clinical trials on record, with 4 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Cardiovascular Disease.

Is Birmingham Clinical Research accredited by Crixeo Health?

Birmingham Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Birmingham Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.